# K992726: Pasco Mic and Mic/ID Panels, Quinupristin/Dalfopristin for Nonfastidious Organisms

- Pathway: 510(k) (Traditional)
- Applicant: Pasco Laboratories, Inc.
- Decided: Nov 3, 1999 after 82 days
- Product code: JTN (Susceptibility Test Discs, Antimicrobial)
- Device class: 2
- Regulation: 21 CFR 866.1620
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
2 later devices descend from it; 2 cite it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K031727: Pasco Mic and Mic/ID Panels, Gemifloxacin (2003), 1 descendant of its own
- K033119: Pasco Mic and Mic/ID Panels (2003), 0 descendants of its own

## Indications for use
Pasco MIC and MIC/ID panels are used for quantitatively measuring (with the exception of the Breakpoint/ID panel which provides qualitative measurement of category results) the susceptibility of rapidly growing aerobic and facultative anaerobic bacterial pathogens to a battery of antimicrobial agents and determining the biochemical identification of those organisms. This 510(k) notification is for the addition of Quinupristin/dalfopristin to Pasco panels at concentrations of 8-0.03 mcg/ml for use in determining the susgeptibility of Staphylococcus aureus (methicillin-susceptible strains only) and Enterococcus faecium (Vancomycin-resistant and multi-drug resistant strains only).

Source page: https://510kreport.com/device/K992726
Methodology: https://510kreport.com/methodology